Consistent with this transgenic study, the identification of senescent-like changes in p21+ and p16Ink4a+ OPCs is associated with amyloid plaques in human AD autopsy neurospecimens and in an APP/PS1 mouse model of AD (Zhang et al., 2019). This evidence concerns the gene CDKN2A and Alzheimer disease.